Amgen Inc (AMGN)
261.22
+1.94
(+0.75%)
USD |
NASDAQ |
Jan 03, 16:00
261.95
+0.73
(+0.28%)
After-Hours: 04:04
Amgen Research and Development Expense (TTM): 5.774B for Sept. 30, 2024
Research and Development Expense (TTM) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
R&D Expense Definition
R&D expense is a line item from many companies' income statements.
Research and Development Expense (TTM) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Research and Development Expense (TTM) Benchmarks
Eli Lilly and Co | 10.53B |
Merck & Co Inc | 22.98B |
Pfizer Inc | 10.60B |
AbbVie Inc | 8.722B |
Viking Therapeutics Inc | 91.16M |